{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:56:51Z","timestamp":1791496611762,"version":"4.3.4"},"reference-count":134,"publisher":"Elsevier BV","issue":"11","content-domain":{"domain":["earlyhumandevelopment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Early Human Development"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.earlhumdev.2013.09.012","type":"journal-article","created":{"date-parts":[[2013,9,29]],"date-time":"2013-09-29T17:18:04Z","timestamp":1380475084000},"page":"865-874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Diagnosis and treatment of pulmonary hypertension in infancy"],"prefix":"10.1016","volume":"89","author":[{"given":"Robin H.","family":"Steinhorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0630","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4103\/2045-8932.83456","article-title":"A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: report from the PVRI Pediatric Taskforce, Panama 2011","volume":"1","author":"Cerro","year":"2011","journal-title":"Pulm Circ"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0635","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.jacc.2004.02.037","article-title":"Clinical classification of pulmonary hypertension","volume":"43","author":"Simonneau","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0640","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0645","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacc.2009.04.013","article-title":"The 4th World Symposium on Pulmonary Hypertension. Introduction","volume":"54","author":"Humbert","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0650","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4103\/2045-8932.83445","article-title":"Functional classification of pulmonary hypertension in children: report from the PVRI pediatric taskforce, Panama 2011","volume":"1","author":"Lammers","year":"2011","journal-title":"Pulm Circ"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0655","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1097\/PCC.0b013e3181c76cdc","article-title":"Neonatal pulmonary hypertension","volume":"11","author":"Steinhorn","year":"2010","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0660","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1542\/peds.105.1.14","article-title":"Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes","volume":"105","author":"Walsh-Sukys","year":"2000","journal-title":"Pediatr"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0665","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jpeds.2006.11.065","article-title":"Early inhaled nitric oxide therapy for term and near-term newborn infants with hypoxic respiratory failure: neurodevelopmental follow-up","volume":"150","author":"Konduri","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0670","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.clp.2011.12.006","article-title":"Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents","volume":"39","author":"Porta","year":"2012","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0005","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.jpeds.2010.11.008","article-title":"Pulmonary hypertension and the asphyxiated newborn","volume":"158","author":"Lapointe","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0010","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1203\/00006450-198712000-00001","article-title":"Fetal lamb ventricles respond differently to filling and arterial pressures and to in utero ventilation","volume":"22","author":"Reller","year":"1987","journal-title":"Pediatr Res"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0015","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/sj.jp.7211673","article-title":"Characteristics of pulmonary hypertension in preterm neonates","volume":"27","author":"Kumar","year":"2007","journal-title":"J Perinatol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0020","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jpeds.2012.03.008","article-title":"Transient defect in nitric oxide generation after rupture of fetal membranes and responsiveness to inhaled nitric oxide in very preterm infants with hypoxic respiratory failure","volume":"161","author":"Aikio","year":"2012","journal-title":"J Pediatr"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0025","doi-asserted-by":"crossref","first-page":"192-8 e3","DOI":"10.1016\/j.jpeds.2011.02.015","article-title":"Morbidity and mortality in late preterm infants with severe hypoxic respiratory failure on extra-corporeal membrane oxygenation","volume":"159","author":"Ramachandrappa","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0030","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1542\/peds.2006-3037","article-title":"Risk factors for persistent pulmonary hypertension of the newborn","volume":"120","author":"Hernandez-Diaz","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0035","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0022-3476(80)80753-0","article-title":"Serum salicylate levels and right-to-left ductus shunts in newborn infants with persistent pulmonary hypertension","volume":"96","author":"Perkin","year":"1980","journal-title":"J Pediatr"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0040","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1542\/peds.107.3.519","article-title":"Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn","volume":"107","author":"Alano","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0045","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1542\/peds.97.5.658","article-title":"Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy","volume":"97","author":"Van Marter","year":"1996","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0050","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1542\/peds.2012-0496","article-title":"Nonsteroidal antiinflammatory drugs in late pregnancy and persistent pulmonary hypertension of the newborn","volume":"131","author":"Van Marter","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0055","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1164\/rccm.200701-163OC","article-title":"Prenatal exposure to fluoxetine induces fetal pulmonary hypertension in the rat","volume":"176","author":"Fornaro","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0060","doi-asserted-by":"crossref","first-page":"L937","DOI":"10.1152\/ajplung.00198.2011","article-title":"Pulmonary vascular effects of serotonin and selective serotonin reuptake inhibitors in the late-gestation ovine fetus","volume":"301","author":"Delaney","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0065","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJMoa052744","article-title":"Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn","volume":"354","author":"Chambers","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0070","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/pds.1570","article-title":"Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn","volume":"17","author":"Kallen","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0075","doi-asserted-by":"crossref","first-page":"d8012","DOI":"10.1136\/bmj.d8012","article-title":"Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries","volume":"344","author":"Kieler","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0080","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/pds.1710","article-title":"Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn","volume":"18","author":"Andrade","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4065\/84.1.23","article-title":"Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy","volume":"84","author":"Wichman","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0090","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-0030-1262507","article-title":"Persistent pulmonary hypertension of the newborn is associated with mode of delivery and not with maternal use of selective serotonin reuptake inhibitors","volume":"28","author":"Wilson","year":"2011","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0095","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1176\/appi.ajp.2011.11040553","article-title":"Persistent pulmonary hypertension of the newborn and selective serotonin reuptake inhibitors: lessons from clinical and translational studies","volume":"169","author":"Occhiogrosso","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0100","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1515\/JPM.2004.030","article-title":"Clinical characteristics and follow up of Down syndrome infants without congenital heart disease who presented with persistent pulmonary hypertension of newborn","volume":"32","author":"Shah","year":"2004","journal-title":"J Perinat Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0105","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00246-006-0011-6","article-title":"Increased incidence of idiopathic persistent pulmonary hypertension in Down syndrome neonates","volume":"28","author":"Cua","year":"2007","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0110","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00431-010-1200-0","article-title":"Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome","volume":"169","author":"Weijerman","year":"2010","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0115","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1542\/peds.107.3.549","article-title":"International experience with trisomy 21 infants placed on extracorporeal membrane oxygenation","volume":"107","author":"Southgate","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0120","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/pr.2011.24","article-title":"Variations in CRHR1 are associated with persistent pulmonary hypertension of the newborn","volume":"71","author":"Byers","year":"2012","journal-title":"Pediatr Res"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0125","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1203\/PDR.0b013e31815b43ee","article-title":"Betamethasone attenuates oxidant stress in endothelial cells from fetal lambs with persistent pulmonary hypertension","volume":"63","author":"Chandrasekar","year":"2008","journal-title":"Pediatr Res"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0130","doi-asserted-by":"crossref","first-page":"L595","DOI":"10.1152\/ajplung.00145.2011","article-title":"Hydrocortisone normalizes oxygenation and cGMP regulation in lambs with persistent pulmonary hypertension of the newborn","volume":"302","author":"Perez","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0135","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1164\/rccm.201010-1697CI","article-title":"Alveolar capillary dysplasia","volume":"184","author":"Bishop","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0140","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ajhg.2009.05.005","article-title":"Genomic and genic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations","volume":"84","author":"Stankiewicz","year":"2009","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0145","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1006\/dbio.2001.0322","article-title":"Defects in pulmonary vasculature and perinatal lung hemorrhage in mice heterozygous null for the Forkhead Box f1 transcription factor","volume":"235","author":"Kalinichenko","year":"2001","journal-title":"Dev Biol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0150","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jpeds.2007.05.054","article-title":"ABCA3 deficiency presenting as persistent pulmonary hypertension of the newborn","volume":"151","author":"Kunig","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0155","first-page":"L969","article-title":"Persistent eNOS in lung hypoplasia caused by left pulmonary artery ligation in the ovine fetus","volume":"272","author":"Tajchman","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0160","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1164\/rccm.200907-1126OC","article-title":"Congenital diaphragmatic hernia: endothelin-1, pulmonary hypertension, and disease severity","volume":"182","author":"Keller","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0165","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/MOP.0b013e3283423e6b","article-title":"The new bronchopulmonary dysplasia","volume":"23","author":"Jobe","year":"2011","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0170","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1164\/rccm.200310-1483OC","article-title":"Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia","volume":"170","author":"Mourani","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ppedcard.2009.09.007","article-title":"Pulmonary hypertension in bronchopulmonary dysplasia","volume":"27","author":"Mourani","year":"2009","journal-title":"Progr Pediatr Cardiol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0180","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4070\/kcj.2010.40.3.131","article-title":"Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia","volume":"40","author":"An","year":"2010","journal-title":"Korean Circ J"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0185","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/jp.2012.164","article-title":"Fetal growth restriction and pulmonary hypertension in premature infants with bronchopulmonary dysplasia","volume":"33","author":"Check","year":"2013","journal-title":"J Perinatol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0190","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MOP.0b013e328360a3f6","article-title":"Pulmonary vascular disease in bronchopulmonary dysplasia: pulmonary hypertension and beyond","volume":"25","author":"Mourani","year":"2013","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0195","doi-asserted-by":"crossref","first-page":"e656","DOI":"10.1542\/peds.2008-0075","article-title":"Pulmonary vein stenosis: prematurity and associated conditions","volume":"122","author":"Drossner","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0200","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1542\/peds.2007-0971","article-title":"Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era","volume":"120","author":"Khemani","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0205","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000327891","article-title":"Risk factors for pulmonary artery hypertension in preterm infants with moderate or severe bronchopulmonary dysplasia","volume":"101","author":"Kim","year":"2012","journal-title":"Neonatology"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0210","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/jp.2010.213","article-title":"Echocardiographic detection of pulmonary hypertension in extremely low birth weight infants with bronchopulmonary dysplasia requiring prolonged positive pressure ventilation","volume":"31","author":"Slaughter","year":"2011","journal-title":"J Perinatol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0215","doi-asserted-by":"crossref","first-page":"e682","DOI":"10.1542\/peds.2011-1827","article-title":"Prospective analysis of pulmonary hypertension in extremely low birth weight infants","volume":"129","author":"Bhat","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0220","doi-asserted-by":"crossref","first-page":"L1011","DOI":"10.1152\/ajplung.2001.281.4.L1011","article-title":"Reduced endothelial nitric oxide synthase in lungs of chronically ventilated preterm lambs","volume":"281","author":"MacRitchie","year":"2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0225","doi-asserted-by":"crossref","first-page":"L749","DOI":"10.1152\/ajplung.00334.2002","article-title":"Pulmonary NO synthase expression is attenuated in a fetal baboon model of chronic lung disease","volume":"284","author":"Afshar","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0230","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1542\/peds.2010-2725","article-title":"Inhaled nitric oxide in preterm infants: an individual-patient data meta-analysis of randomized trials","volume":"128","author":"Askie","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0235","doi-asserted-by":"crossref","first-page":"L76","DOI":"10.1152\/ajplung.00395.2002","article-title":"Pulmonary vascular dysfunction in preterm lambs with chronic lung disease","volume":"285","author":"Bland","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0240","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1542\/peds.2004-0525","article-title":"Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn","volume":"114","author":"Reynolds","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0245","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jpeds.2011.06.038","article-title":"B-type natriuretic peptide and rebound during treatment for persistent pulmonary hypertension","volume":"160","author":"Vijlbrief","year":"2012","journal-title":"J Pediatr"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0250","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1542\/peds.97.1.48","article-title":"Surfactant replacement therapy for meconium aspiration syndrome","volume":"97","author":"Findlay","year":"1996","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0255","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0022-3476(98)70482-2","article-title":"Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. Survanta in Term Infants Study Group","volume":"132","author":"Lotze","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0260","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1164\/ajrccm.162.2.9911026","article-title":"Injurious effects of hypocapnic alkalosis in the isolated lung","volume":"162","author":"Laffey","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0265","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(96)04100-1","article-title":"UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation","volume":"348","author":"UK Collaborative ECMO Trial Group","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0270","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.clp.2012.06.006","article-title":"The pulmonary circulation in neonatal respiratory failure","volume":"39","author":"Lakshminrusimha","year":"2012","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0275","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1203\/01.pdr.0000191136.69142.8c","article-title":"Pulmonary arterial contractility in neonatal lambs increases with 100% oxygen resuscitation","volume":"59","author":"Lakshminrusimha","year":"2006","journal-title":"Pediatr Res"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0280","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1152\/japplphysiol.00711.2011","article-title":"Pulmonary hemodynamics and vascular reactivity in asphyxiated term lambs resuscitated with 21 and 100% oxygen","volume":"111","author":"Lakshminrusimha","year":"2011","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0285","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1203\/PDR.0b013e3181bab0c7","article-title":"Oxygen concentration and pulmonary hemodynamics in newborn lambs with pulmonary hypertension","volume":"66","author":"Lakshminrusimha","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0290","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/S0140-6736(10)60543-0","article-title":"Resuscitation of newborn infants: from oxygen to room air","volume":"376","author":"Saugstad","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0295","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jpeds.2010.06.010","article-title":"Medical therapy for pediatric pulmonary arterial hypertension","volume":"157","author":"Tissot","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0300","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/MOP.0b013e3283464a52","article-title":"Recent progress in understanding pediatric pulmonary hypertension","volume":"23","author":"Abman","year":"2011","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0305","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.4187\/respcare.01297","article-title":"Advances in the management of pediatric pulmonary hypertension","volume":"56","author":"Oishi","year":"2011","journal-title":"Respir Care"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0310","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1124\/mi.3.5.253","article-title":"S-nitrosylation signaling in cell biology","volume":"3","author":"Gaston","year":"2003","journal-title":"Mol Interv"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0315","doi-asserted-by":"crossref","first-page":"H376","DOI":"10.1152\/ajpheart.1993.265.1.H376","article-title":"Increasing oxygen tension dilates fetal pulmonary circulation via endothelium-derived relaxing factor","volume":"265","author":"Tiktinsky","year":"1993","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0320","doi-asserted-by":"crossref","first-page":"L232","DOI":"10.1152\/ajplung.00393.2004","article-title":"eNOS function is developmentally regulated: uncoupling of eNOS occurs postnatally","volume":"290","author":"Mata-Greenwood","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0325","doi-asserted-by":"crossref","first-page":"L979","DOI":"10.1152\/ajplung.90238.2008","article-title":"Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertension","volume":"295","author":"Farrow","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0330","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1067\/mpd.2003.140","article-title":"Noninvasive delivery of inhaled nitric oxide therapy for late pulmonary hypertension in newborn infants with congenital diaphragmatic hernia","volume":"142","author":"Kinsella","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0335","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.freeradbiomed.2010.04.020","article-title":"Transport rather than diffusion-dependent route for nitric oxide gas activity in alveolar epithelium","volume":"49","author":"Brahmajothi","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0340","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1542\/peds.113.3.559","article-title":"A randomized trial of early versus standard inhaled nitric oxide therapy in term and near-term newborn infants with hypoxic respiratory failure","volume":"113","author":"Konduri","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0345","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/jp.2009.171","article-title":"Randomized controlled trial of early compared with delayed use of inhaled nitric oxide in newborns with a moderate respiratory failure and pulmonary hypertension","volume":"30","author":"Gonzalez","year":"2010","journal-title":"J Perinatol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0350","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1542\/peds.99.6.838","article-title":"Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia","volume":"99","author":"Neonatal Inhaled Nitric Oxide Study Group","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0355","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jpeds.2005.12.024","article-title":"Neonatal extracorporeal life support: impact of new therapies on survival","volume":"148","author":"Fliman","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0360","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.1542\/peds.2010-3428","article-title":"Inhaled nitric oxide in preterm infants: a systematic review","volume":"127","author":"Donohue","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0365","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1542\/peds.2011-1270A","article-title":"Inhaled nitric oxide and bronchopulmonary dysplasia","volume":"128","author":"Steinhorn","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0370","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJMoa061088","article-title":"Inhaled nitric oxide in preterm infants undergoing mechanical ventilation","volume":"355","author":"Ballard","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0375","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jpeds.2008.04.033","article-title":"One-year respiratory outcomes of preterm infants enrolled in the nitric oxide (to prevent) chronic lung disease trial","volume":"153","author":"Hibbs","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0380","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJM200106143442404","article-title":"Neonatal pulmonary hypertension\u2013urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function","volume":"344","author":"Pearson","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0385","doi-asserted-by":"crossref","first-page":"L506","DOI":"10.1152\/ajplung.00017.2009","article-title":"l-Citrulline ameliorates chronic hypoxia-induced pulmonary hypertension in newborn piglets","volume":"297","author":"Ananthakrishnan","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0390","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jtcvs.2006.02.012","article-title":"Nitric oxide precursors and congenital heart surgery: a randomized controlled trial of oral citrulline","volume":"132","author":"Smith","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0395","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jtcvs.2007.02.043","article-title":"Pharmacokinetics and safety of intravenously administered citrulline in children undergoing congenital heart surgery: potential therapy for postoperative pulmonary hypertension","volume":"134","author":"Barr","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0400","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1164\/ajrccm.164.5.2010104","article-title":"Recombinant human superoxide dismutase enhances the effect of inhaled nitric oxide in persistent pulmonary hypertension","volume":"164","author":"Steinhorn","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0405","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1161\/01.RES.0000063424.28903.BB","article-title":"Increased superoxide generation is associated with pulmonary hypertension in fetal lambs: a role for NADPH oxidase","volume":"92","author":"Brennan","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0410","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1164\/rccm.200605-676OC","article-title":"Superoxide dismutase improves oxygenation and reduces oxidation in neonatal pulmonary hypertension","volume":"174","author":"Lakshminrusimha","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0415","doi-asserted-by":"crossref","first-page":"L109","DOI":"10.1152\/ajplung.00309.2009","article-title":"Superoxide dismutase and inhaled nitric oxide normalize phosphodiesterase 5 expression and activity in neonatal lambs with persistent pulmonary hypertension","volume":"299","author":"Farrow","year":"2010","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0420","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-3-642-17969-3_11","article-title":"Phosphodiesterases: emerging therapeutic targets for neonatal pulmonary hypertension","author":"Farrow","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0425","first-page":"348A","article-title":"cGMP-binding, cGMP-specific phosphodiesterase gene expression is regulated during lung development","volume":"37","author":"Sanchez","year":"1995","journal-title":"Pediatr Res"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0430","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.resp.2010.08.018","article-title":"Mitochondrial oxidant stress increases PDE5 activity in persistent pulmonary hypertension of the newborn","volume":"174","author":"Farrow","year":"2010","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0435","doi-asserted-by":"crossref","first-page":"L109","DOI":"10.1152\/ajplung.00309.2009","article-title":"SOD and inhaled nitric oxide normalize phosphodiesterase 5 expression and activity in neonatal lambs with persistent pulmonary hypertension","volume":"299","author":"Farrow","year":"2010","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0440","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/CIRCULATIONAHA.106.655266","article-title":"Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility","volume":"116","author":"Nagendran","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0445","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00000542-199907000-00041","article-title":"Sildenafil ameliorates effects of inhaled nitric oxide withdrawal","volume":"91","author":"Atz","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0450","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/0885066608321389","article-title":"Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease","volume":"23","author":"Lee","year":"2008","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0455","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1164\/rccm.200605-694OC","article-title":"Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children","volume":"174","author":"Namachivayam","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0460","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1542\/peds.2005-0523","article-title":"Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study","volume":"117","author":"Baquero","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0465","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jpeds.2009.06.012","article-title":"Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension","volume":"155","author":"Steinhorn","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0470","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1465-9921-10-30","article-title":"Sildenafil attenuates pulmonary inflammation and fibrin deposition, mortality and right ventricular hypertrophy in neonatal hyperoxic lung injury","volume":"10","author":"de Visser","year":"2009","journal-title":"Respir Res"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0475","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1164\/rccm.200503-510OC","article-title":"Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury","volume":"172","author":"Ladha","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0480","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1165\/rcmb.2012-0043OC","article-title":"Sildenafil alleviates bronchopulmonary dysplasia in neonatal rats by activating the hypoxia-inducible factor signaling pathway","volume":"48","author":"Park","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0485","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jpeds.2008.09.021","article-title":"Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease","volume":"154","author":"Mourani","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0490","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/01.PCC.0000244401.53189.CB","article-title":"Abnormal vascular tone in infants and children with lung hypoplasia: findings from cardiac catheterization and the response to chronic therapy","volume":"7","author":"Keller","year":"2006","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0495","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCULATIONAHA.110.016667","article-title":"A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension","volume":"125","author":"Barst","year":"2012","journal-title":"Circulation"},{"issue":"Suppl. 1","key":"10.1016\/j.earlhumdev.2013.09.012_bb0500","first-page":"979","article-title":"STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive patients with pediatric pulmonary arterial hypertension (abstract)","volume":"33","author":"Barst","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0505","first-page":"L66","article-title":"Ontogeny of cyclooxygenase-1 and cyclooxygenase-2 gene expression in ovine lung","volume":"274","author":"Brannon","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0510","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1172\/JCI117220","article-title":"Prostacyclin synthesis in ovine pulmonary artery is developmentally regulated by changes in cyclooxygenase-1 gene expression","volume":"93","author":"Brannon","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0515","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199207093270202","article-title":"An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension","volume":"327","author":"Christman","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0520","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/PCC.0b013e3181936aee","article-title":"Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent pulmonary hypertension of the newborn","volume":"10","author":"Lakshminrusimha","year":"2009","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0525","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1440-1681.1997.tb02730.x","article-title":"Prostanoid action on the human pulmonary vascular system","volume":"24","author":"Jones","year":"1997","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0530","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1164\/ajrccm.153.3.8630585","article-title":"Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome","volume":"153","author":"Walmrath","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0535","doi-asserted-by":"crossref","first-page":"F214","DOI":"10.1136\/fn.71.3.F214","article-title":"Aerosolised prostacyclin for pulmonary hypertension in neonates","volume":"71","author":"Bindl","year":"1994","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0540","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s001340050498","article-title":"Improvement of oxygenation induced by aerosolized prostacyclin in a preterm infant with persistent pulmonary hypertension of the newborn","volume":"23","author":"Soditt","year":"1997","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0545","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/sj.jp.7211811","article-title":"Can inhaled prostacyclin stimulate surfactant in ELBW infants?","volume":"27","author":"Olmsted","year":"2007","journal-title":"J Perinatol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0550","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1067\/mpd.2002.129849","article-title":"Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide","volume":"141","author":"Kelly","year":"2002","journal-title":"J Pediatr"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0555","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1203\/PDR.0b013e3181bce574","article-title":"Regulation of phosphodiesterase 3 in the pulmonary arteries during the perinatal period in sheep","volume":"66","author":"Chen","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0560","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/PCC.0b013e318250af44","article-title":"Inodilators in nitric oxide resistant persistent pulmonary hypertension of the newborn","volume":"14","author":"Lakshminrusimha","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0565","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1152\/japplphysiol.01082.2009","article-title":"Prostacyclin and milrinone by aerosolization improve pulmonary hemodynamics in newborn lambs with experimental pulmonary hypertension","volume":"109","author":"Kumar","year":"2010","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0570","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00003246-200003000-00031","article-title":"Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertension","volume":"28","author":"Deb","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0575","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/01.PCC.0000124021.25393.2D","article-title":"Phosphodiesterase-3 inhibition prevents the increase in pulmonary vascular resistance following inhaled nitric oxide withdrawal in lambs","volume":"5","author":"Thelitz","year":"2004","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0580","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jcrc.2006.01.001","article-title":"Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn","volume":"21","author":"McNamara","year":"2006","journal-title":"J Crit Care"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0585","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/PCC.0b013e31824ea2cd","article-title":"Pharmacology of milrinone in neonates with persistent pulmonary hypertension of the newborn (PPHN) and suboptimal response to inhaled nitric oxide","volume":"14","author":"McNamara","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0590","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1146\/annurev.med.59.110106.212434","article-title":"Role of endothelin receptor antagonists in the treatment of pulmonary arterial hypertension","volume":"60","author":"Abman","year":"2009","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0595","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","article-title":"Expression of endothelin-1 in the lungs of patients with pulmonary hypertension","volume":"328","author":"Giaid","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0600","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jacc.2005.01.066","article-title":"Effects of long-term bosentan in children with pulmonary arterial hypertension","volume":"46","author":"Rosenzweig","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0605","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/hrt.2005.072314","article-title":"Response to bosentan in children with pulmonary hypertension","volume":"92","author":"Maiya","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0610","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/j.1651-2227.2009.01386.x","article-title":"Successful treatment of persistent pulmonary hypertension of the newborn with bosentan","volume":"98","author":"Nakwan","year":"2009","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0615","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00431-007-0531-y","article-title":"Persistent pulmonary hypertension of the newborn with transposition of the great arteries: successful treatment with bosentan","volume":"167","author":"Goissen","year":"2008","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0620","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/jp.2011.157","article-title":"A randomized, double-blind, placebo-controlled, prospective study of bosentan for the treatment of persistent pulmonary hypertension of the newborn","volume":"32","author":"Mohamed","year":"2012","journal-title":"J Perinatol"},{"key":"10.1016\/j.earlhumdev.2013.09.012_bb0625","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1203\/PDR.0b013e318179954c","article-title":"Safety experience with bosentan in 146 children 2\u201311years old with pulmonary arterial hypertension: results from the European Postmarketing Surveillance program","volume":"64","author":"Beghetti","year":"2008","journal-title":"Pediatr Res"}],"container-title":["Early Human Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378213002338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378213002338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T04:14:02Z","timestamp":1646626442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378378213002338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":134,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0378378213002338"],"URL":"https:\/\/doi.org\/10.1016\/j.earlhumdev.2013.09.012","relation":{},"ISSN":["0378-3782"],"issn-type":[{"value":"0378-3782","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and treatment of pulmonary hypertension in infancy","name":"articletitle","label":"Article Title"},{"value":"Early Human Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.earlhumdev.2013.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}